Evidence map›Paper›PMID 38175863›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Lipid shape and packing are key for optimal design of pH-sensitive mRNA lipid nanoparticles.

Giulio Tesei, Ya-Wen Hsiao, Aleksandra Dabkowska, Gunnar Grönberg, Marianna Yanez Arteta, David Ulkoski, David J Bray, Martin Trulsson, Johan Ulander, Mikael Lund and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Decoding pH-Driven Phase Transition of Lipid Nanoparticles.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Immunology of RNA-based vaccines: The critical interplay between inflammation and expression.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giulio TeseiStructural Biology and NMR Laboratory & The Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen DK-2200, Denmark.ORCID 0000-0003-4339-4460
Ya-Wen HsiaoThe Hartree Centre, Science and Technology Facilities Council (STFC) Daresbury Laboratory, Warrington WA4 4AD, United Kingdom.
Aleksandra DabkowskaAdvanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden.
Gunnar GrönbergMedicinal Chemistry, Early Respiratory & Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden.ORCID 0009-0004-3898-732X
Marianna Yanez ArtetaAdvanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden.ORCID 0000-0002-4521-3275
David UlkoskiAdvanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden.ORCID 0000-0001-5284-1977
David J BrayThe Hartree Centre, Science and Technology Facilities Council (STFC) Daresbury Laboratory, Warrington WA4 4AD, United Kingdom.ORCID 0000-0002-6107-0091
Martin TrulssonDepartment of Chemistry, Division of Computational Chemistry, Lund University, Lund SE-221 00, Sweden.ORCID 0000-0002-5398-9145
Johan UlanderData Science and Modelling, Pharmaceutical Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden.
Mikael LundDepartment of Chemistry, Division of Computational Chemistry, Lund University, Lund SE-221 00, Sweden.ORCID 0000-0001-8178-8175
Lennart LindforsAdvanced Drug Delivery, Pharmaceutical Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Mölndal 431 83, Sweden.ORCID 0000-0002-6711-0605

Funding

Vetenskapsrådet (VR) 2022-04251
6 · The paper itself

Abstract

The ionizable-lipid component of RNA-containing nanoparticles controls the pH-dependent behavior necessary for an efficient delivery of the cargo-the so-called endosomal escape. However, it is still an empirical exercise to identify optimally performing lipids. Here, we study two well-known ionizable lipids, DLin-MC3-DMA and DLin-DMA using a combination of experiments, multiscale computer simulations, and electrostatic theory. All-atom molecular dynamics simulations, and experimentally measured polar headgroup p

Indexed as

LipidsNanoparticlesHydrogen-Ion ConcentrationLiposomesMolecular Dynamics SimulationRNA, MessengerRNA, Small InterferingLipid NanoparticlesLipidsLiposomesRNA, MessengerRNA, Small Interferinglipid ionizationlipid nanoparticlepH controlled releaseRNA encapsulation

Identifiers

PMID38175863
PMCPMC10786277

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.